Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1

• Johnny Donovan,
• Zicheng Deng,
• Zicheng Deng,
• Zicheng Deng,
• Fenghua Bian,
• Samriddhi Shukla,
• Jose Gomez-Arroyo,
• Jose Gomez-Arroyo,
• Donglu Shi,
• Vladimir V. Kalinichenko,
• Vladimir V. Kalinichenko,
• Tanya V. Kalin

Affiliations

Johnny Donovan

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Zicheng Deng

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Zicheng Deng

The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States

Zicheng Deng

Center for Lung Regenerative Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Fenghua Bian

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Samriddhi Shukla

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Jose Gomez-Arroyo

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Jose Gomez-Arroyo

Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States

Donglu Shi

The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States

Vladimir V. Kalinichenko

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Vladimir V. Kalinichenko

Center for Lung Regenerative Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States

Tanya V. Kalin

Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States